Cerevel Therapeutics Holdings Inc (CERE)
42.35
+0.04
(+0.09%)
USD |
NASDAQ |
May 16, 16:00
42.34
-0.02
(-0.04%)
After-Hours: 20:00
Cerevel Therapeutics Holdings Stock Buybacks (Quarterly): 0.075M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.075M |
| December 31, 2023 | -498.94M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.057M |
| September 30, 2022 | -238.32M |
| June 30, 2022 |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -328.25M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-498.94M
Minimum
Dec 2023
0.075M
Maximum
Mar 2024
-106.54M
Average
--
Median
Sep 2020
Stock Buybacks (Quarterly) Benchmarks
| AbbVie Inc | 1.324B |
| Immunogen Inc (DELISTED) | 0.034M |
| Bristol-Myers Squibb Co | 0.00 |
| Madrigal Pharmaceuticals Inc | -311.56M |
| Viking Therapeutics Inc | -597.12M |